Archive for the ‘Treatment’ Category
Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer
July 23rd, 2009
Debi wrote a good post today on
Here’s a little excerpt
Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy alone. The results of this study were published in the Journal of the National Cancer Institute.
Read the rest of this great post here
Posted in 
SLU compares two treatments for lung cancer
July 22nd, 2009
Debi wrote a good post today on
Here’s a little excerpt
St. Louis University researchers are comparing two standard treatments for lung cancer — one that uses surgery to remove the tumor and another that delivers high, focused doses of radiation with a robot.
The clinical trial will compare the three-year survival rate of patients who have a lobectomy with those who use the radiation treatment with the robotic CyberKnife. Participants must have early-stage non-small cell lung cancer, the most common form of lung cancer.
Read the rest of this great post here
New Treatment Strategy Enhances Outcome for Lung Cancer
June 2nd, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
A new strategy for treating non-small cell lung cancer increases the effectiveness of standard chemotherapy in patients with advanced stage disease, according to results presented at the American Society of Clinical Oncology meeting in Orlando.
Read the rest of this great post here
Bayer tests Nexavar against lung cancer in Phase III
June 1st, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
Bayer and Onyx Pharmaceuticals have started a late-stage trial testing its drug hopeful Nexavar on lung tumours in a fresh attempt to get the treatment approved against the most common cancer form.
The study in the third and last phase of testing usually required for regulatory clearance will involve about 850 lung cancer patients who could not be helped by two or three previous treatments, the companies said on Monday.
Read the rest of this great post here
Gemin X Announces Positive Results in Small Cell Lung Cancer from Phase 1b Trial of Obatoclax at Annual Meeting of the American Society of Clinical Oncology
May 30th, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today presented positive results from a Phase 1b clinical trial of its lead product candidate obatoclax (GX15-070) for the treatment of first line patients with extensive-stage small cell lung cancer (SCLC).
Read the rest of this great post here
Merck KGaA’s says cancer vaccine safe in study
May 30th, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
Merck KGaA’s experimental cancer vaccine Stimuvax proved safe to use in a long-term Phase II study on lung cancer patients, the German drugmaker said on Saturday.
The trial showed that patients’ immune systems did not turn on normal cells, a major concern in new vaccines that are designed to prime the body’s immune system to detect and attack cancer cells.
Read the rest of this great post here
Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
May 30th, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
Data from the Phase III ZODIAC study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, demonstrating that the addition of vandetanib to docetaxel resulted in a statistically significant improvement in progression-free survival (PFS), the length of time a patient lives without their cancer growing.
Read the rest of this great post here
Biodesix launches cancer test
May 8th, 2009
Quit Smoking Help wrote an interesting post today on
Here’s a quick excerpt
BROOMFIELD – Biodesix Inc. in Broomfield has launched a test to help oncologists guide treatment of patients with lung cancer.
Read the rest of this great post here
Concurrent Chemoradiation Lengthens Lung Cancer Survival
May 7th, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
NEW YORK (Reuters Health) – Concurrent chemoradiation is associated with the longest survival in patients with advanced non-small cell lung cancer (NSCLC), according to US and Chinese researchers.
However, senior investigator Dr. Feng-Ming Kong of the University of Michigan, Ann Arbor, told Reuters Health, “although high-doseradiation therapy and chemotherapy improve the treatment results, the long-term survival rates from this study remain poor.” She added that survival rates are “much better” in patients treated more recently.
Read the rest of this great post here
New lung cancer radiation therapy created
March 9th, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
U.S. radiologists say they have developed a new lung cancer treatment that avoids conventional radiation regimens or surgical procedures. that avoids conventional radiation regimens or surgical procedures. Temple University Professor Curtis Miyamoto, who led the research, said the technique — stereotactic body radiotherapy — improves the odds of surviving early stage lung cancer.
that avoids conventional radiation regimens or surgical procedures. Temple University Professor Curtis Miyamoto, who led the research, said the technique — stereotactic body radiotherapy — improves the odds of surviving early stage lung cancer.”With the success of this technique, we’re now questioning whether we’ll even be doing surgeries on these patients in the future,” Miyamoto said.
Read the rest of this great post here